Impact of genomic testing and patient-reported outcomes on receipt of adjuvant chemotherapy

Practice guidelines incorporate genomic tumor profiling, using results such as the Oncotype DX Recurrence Score (RS), to refine recurrence risk estimates for the large proportion of breast cancer patients with early-stage, estrogen receptor-positive disease. We sought to understand the impact of rec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Evans, Chalanda N., Brewer, Noel T., Vadaparampil, Susan T., Boisvert, Marc, Ottaviano, Yvonne, Lee, M. Catherine, Isaacs, Claudine, Schwartz, Marc D., O’Neill, Suzanne C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5065914/
https://ncbi.nlm.nih.gov/pubmed/27059031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3780-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados